Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TP53 Mutation by CRISPR System Enhances the Malignant Potential of Colon Cancer

15 Apr 2019

Abstract excerpt

Abstract Tumor protein p53 (TP53) mutation is a well-known occurrence at the late phase of carcinogenesis during the adenoma–carcinoma sequence of a sporadic colon cancer. Although numerous reports about clinical information of the patients with colon cancer have suggested that TP53 mutation might be related to various types of malignant potential, the direct effects of this mutation on the malignant potential of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer-related Molecular Pathways
Share to Cancer Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30988165
DOI: 10.1158/1541-7786.mcr-18-1195

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TP53 Mutation by CRISPR System Enhances the Malignant Potential of Colon CancerPMID 30988165Read ↗

p53 in colorectal cancer: from a master player to a privileged therapy target.Semantic proximity Read ↗

P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAsSemantic proximity Read ↗

Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors.Semantic proximity Read ↗

Restoring the p53 'Guardian' Phenotype in p53-Deficient Tumor Cells with CRISPR/Cas9.Semantic proximity Read ↗

Therapeutic implications of colon cancer stem cellsSemantic proximity Read ↗

Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells.Semantic proximity Read ↗

CRISPR/Cas9: a powerful tool in colorectal cancer researchSemantic proximity Read ↗

Colorectal cancer is associated with the presence of cancer driver mutations in normal colonSemantic proximity Read ↗

Cancer Stem Cells in Colorectal Cancer: Genetic and Epigenetic ChangesSemantic proximity Read ↗

P53 mutations in colorectal cancer - molecular pathogenesis and pharmacological reactivation.Semantic proximity Read ↗

Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancerSemantic proximity Read ↗

Sequential cancer mutations in cultured human intestinal stem cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.